In general, these drugs improve BMD, reduce fracture risk, and tend to normalize serum alkaline phosphatase and calcium homeostasis in hypermetabolic states (Table 2).

• 总的来说，这类药物可以提高骨矿物质密度、减少骨折风险并且可以纠正代谢亢进的血碱性磷酸酶及血钙水平。